BamSEC and AlphaSense Join Forces
Learn More

Vertex Pharmaceuticals Incorporated

NASDAQ: VRTX    
Share price (12/20/24): $397.27    
Market cap (12/20/24): $102 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-K 3 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 10-K 2 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-K 3 pages Indenture or similar
12/34/56
EX-4.2
from S-3ASR 88 pages Vertex Pharmaceuticals Incorporated Indenture Debt Securities =================================================================== Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture*
12/34/56
EX-4.5
from S-3ASR 39 pages Form of Subordinated Indenture Vertex Pharmaceuticals Incorporated, Issuer and [ ], Trustee Indenture Dated as of [ ], 201[ ] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3ASR 38 pages Form of Senior Indenture Vertex Pharmaceuticals Incorporated, Issuer and [ ], Trustee Indenture Dated as of [ ], 201[ ] Senior Debt Securities
12/34/56
EX-4.3
from 8-K 15 pages Interest Payment Dates: April 1 and October 1, Commencing April 1, 2011
12/34/56
EX-4.2
from 8-K 86 pages First Supplemental Indenture Between Vertex Pharmaceuticals Incorporated, as Issuer and U.S. Bank National Association, as Trustee Dated as of September 28, 2010 Establishing the Series of Securities Designated as 3.35% Convertible Senior Subordinated Notes Due 2015
12/34/56
EX-4.1
from 8-K 40 pages Subordinated Indenture Vertex Pharmaceuticals Incorporated, Issuer and U.S. Bank National Association, Trustee Indenture Dated as of September 28, 2010 Subordinated Debt Securities
12/34/56
EX-4.8
from S-3ASR 45 pages Form of Subordinated Indenture Vertex Pharmaceuticals Incorporated, Issuer and [ ], Trustee Indenture Dated as of [ ], 201[ ] Subordinated Debt Securities
12/34/56
EX-4.7
from S-3ASR 45 pages Form of Senior Indenture Vertex Pharmaceuticals Incorporated, Issuer and [ ], Trustee Indenture Dated as of [ ], 201[ ] Senior Debt Securities
12/34/56
EX-4.2
from 10-Q 12 pages (Face of Note) Vertex Pharmaceuticals Incorporated Secured Notes Due 2012
12/34/56
EX-4.1
from 10-Q 99 pages Confidential Portions of This Document Have Been Redacted and Have Been Separately Filed With the Commission. Vertex Pharmaceuticals Incorporated $155,000,000 Secured Notes Due 2012 Indenture Dated as of September 30, 2009 U.S. Bank National Association, as Trustee and Collateral Agent Information Redacted Pursuant to a Confidential Treatment Request. an Unredacted Version of This Exhibit Has Been Filed Separately With the Commission
12/34/56
EX-4.1
from 8-K 32 pages Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 99 pages Indenture Between Vertex Pharmaceuticals Incorporated, as Issuer and U.S. Bank National Association, as Trustee 4.75% Convertible Senior Subordinated Notes Due 2013 Dated as of February 19, 2008
12/34/56
EX-4.1
from S-3ASR 94 pages Indenture Between Vertex Pharmaceuticals Incorporated, as Issuer and U.S. Bank National Association, as Trustee [ ]% Convertible Senior Subordinated Notes Due 2013 Dated as of February [ ], 2008
12/34/56
EX-4.5
from S-3ASR 11 pages Resale Registration Rights Agreement
12/34/56
EX-4.5
from S-3ASR 8 pages Resale Registration Rights Agreement
12/34/56
EX-4.5
from S-3ASR 10 pages Resale Registration Rights Agreement
12/34/56
EX-4.5
from S-3 ~50 pages Indenture or similar
12/34/56